Episode Details

In our latest Trade To Black podcast, hosts Shadd Dales and Anthony Varrell welcomed Rubicon Organics CEO Margaret Brodie to break down the company’s impressive 2024 earnings. Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) posted a 21% year-over-year revenue jump, hitting $48.7 million. The company, known for its premium and organic cannabis products, made significant headway in vapes, flower, and brand development—setting the stage for a stronger 2025.CEO Brodie credited the success to combining top-tier branding with quality products, highlighting that their full-spectrum vapes captured 13.4% market share within six months. As Canadian cannabis faces supply strain, Rubicon’s agility positions it well for continued growth. Plans are already in motion for a 47,500 sq. ft. expansion in Hope, BC, aiming to boost capacity by 40% and increase annual output to 15,500 kg.Plus, recent news from a bill from Rep. Mikie Sherrill (D-NJ), proposing drug testing for Elon Musk and others working in sensitive government roles under the Department of Government Efficiency (DOGE).Finally, Frank Colombo, CFA from Viridian Capital returns to unpack the cannabis capital crunch, including the latest defaults in the industry, along with the Chapter 11 bankruptcy filing of Gold Flora. 0:00:00 Intro0:00:20 Market Overview and Cannabis Industry News0:01:37 Tariffs Impact on Cannabis MarketFrank Colombo's Interview0:04:47 Cannabis Companies Financial Analysis0:10:38 Company Default Risks and Warning Signs0:17:08 International Cannabis Market Outlook0:20:48 Potential Regulatory Reform ImpactMargaret Brodie's Interview0:24:20 - Meeting Introduction and Initial Conversation0:24:48 - Discussion of European Market Opportunities0:25:41 - Canadian Cannabis Market Experiences0:27:47 - Financial Performance and Revenue Highlights0:30:31 - Strategy for Canadian and European Markets0:34:27 - Untapped Market Share and Product Demand0:36:06 - Product Growth Drivers and New Product Launches0:38:23 - Product Listing and Delisting Strategies0:42:23 - Capital Deployment and Acquisition Plans0:44:13 - Closing Remark